SCHEMBL16219581

SCHEMBL16219581

Cc1c(F)cc2ccccc2c1-c1c(C(C)(C)C)c(F)cc2ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.35
▸ CYP2A6 P11509 3/20 0.35
▸ HPRT1 P00492 1/20 0.33
▸ GPR84 Q9NQS5 1/20 0.33
▸ TSHR P16473 2/20 0.32
▸ ALDH1A1 P00352 4/20 0.32
▸ HSD17B10 Q99714 3/20 0.32
▸ HPGD P15428 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ HIF1A Q16665 2/20 0.31
▸ CYP1B1 Q16678 1/20 0.31
▸ ALOX5 P09917 1/20 0.31
▸ NQO2 P16083 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ CASP1 P29466 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ CASP7 P55210 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24449220 0.84 CYP1A2 (0.39) CYP1A2CYP2A6HPRT1TSHRALDH1A1
SCHEMBL16219575 0.80 ALDH1A1 (0.46) HPRT1GPR84ALDH1A1HPGDKDM4E
SCHEMBL14297119 0.78 KDM4E (0.35) CYP1A2CYP2A6HPRT1ALDH1A1HPGD
SCHEMBL16219583 0.75 ALDH1A1 (0.34) CYP1A2CYP2A6GPR84TSHRALDH1A1
SCHEMBL16222598 0.75 ALDH1A1 (0.48) CYP1A2CYP2A6HPRT1GPR84ALDH1A1
SCHEMBL24446570 0.74 CYP2A6 (0.46) CYP1A2CYP2A6HPRT1TSHRALDH1A1
SCHEMBL26058913 0.72 HPRT1 (0.35) CYP1A2CYP2A6HPRT1TSHRALDH1A1
SCHEMBL12017092 0.72 CYP2A6 (0.43) CYP1A2CYP2A6HPRT1TSHRALDH1A1
SCHEMBL24859351 0.69 ALDH1A1 (0.44) CYP1A2CYP2A6TSHRALDH1A1HSD17B10
SCHEMBL12583259 0.69 MBNL1 (0.42) CYP1A2CYP2A6GPR84TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9441059-B2 Metathesis catalysts and methods thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2016-09-13 — — US disclosed
US-20140378637-A1 METATHESIS CATALYSTS AND METHODS THEREOF NATIONAL SCIENCE FOUNDATION 2014-12-25 — — US disclosed
US-20140330018-A1 METATHESIS CATALYSTS AND METHODS THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2014-11-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140330018-A1 METATHESIS CATALYSTS AND METHODS THEREOF TERT, CYP19A1, MPO CYP1A2 22/4885CYP2A6 165/4885HPRT1 808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback